Carter Bruce L A - Net Worth and Insider Trading

Carter Bruce L A Net Worth

The estimated net worth of Carter Bruce L A is at least $1 Million dollars as of 2024-04-25. Carter Bruce L A is the Director of Xencor Inc and owns about 48,578 shares of Xencor Inc (XNCR) stock worth over $923,954. Carter Bruce L A is the Director of Mirati Therapeutics Inc and owns about 6,021 shares of Mirati Therapeutics Inc (MRTX) stock worth over $353,433. Carter Bruce L A is also the Director of Enanta Pharmaceuticals Inc and owns about 0 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $0. Besides these, Carter Bruce L A also holds Regulus Therapeutics Inc (RGLS) . Details can be seen in Carter Bruce L A's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carter Bruce L A has not made any transactions after 2022-08-12 and currently still holds the listed stock(s).

Transaction Summary of Carter Bruce L A

To

Carter Bruce L A Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carter Bruce L A owns 6 companies in total, including Mirati Therapeutics Inc (MRTX) , Enanta Pharmaceuticals Inc (ENTA) , and Xencor Inc (XNCR) among others .

Click here to see the complete history of Carter Bruce L A’s form 4 insider trades.

Insider Ownership Summary of Carter Bruce L A

Ticker Comapny Transaction Date Type of Owner
MRTX Mirati Therapeutics Inc 2022-08-12 director
ENTA Enanta Pharmaceuticals Inc 2022-03-21 director
XNCR Xencor Inc 2017-06-14 director
RGLS Regulus Therapeutics Inc 2015-04-13 director
NVLNF Novelion Therapeutics Inc 2011-05-26 director
ALOR ALSP Orchid Acquisition Corp I 2021-11-18 director

Carter Bruce L A Latest Holdings Summary

Carter Bruce L A currently owns a total of 4 stocks. Among these stocks, Carter Bruce L A owns 48,578 shares of Xencor Inc (XNCR) as of June 14, 2017, with a value of $923,954 and a weighting of 72.33%. Carter Bruce L A owns 6,021 shares of Mirati Therapeutics Inc (MRTX) as of August 12, 2022, with a value of $353,433 and a weighting of 27.67%. Carter Bruce L A also owns 0 shares of Enanta Pharmaceuticals Inc (ENTA) as of March 21, 2022, with a value of $0 and a weighting of 0%. The other 1 stocks Regulus Therapeutics Inc (RGLS) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Carter Bruce L A

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XNCR Xencor Inc 2017-06-14 48,578 19.02 923,954
MRTX Mirati Therapeutics Inc 2022-08-12 6,021 58.70 353,433
ENTA Enanta Pharmaceuticals Inc 2022-03-21 0 12.92 0
RGLS Regulus Therapeutics Inc 2015-04-13 0 2.22 0

Holding Weightings of Carter Bruce L A


Carter Bruce L A Form 4 Trading Tracker

According to the SEC Form 4 filings, Carter Bruce L A has made a total of 0 transactions in Xencor Inc (XNCR) over the past 5 years. The most-recent trade in Xencor Inc is the sale of 20,000 shares on June 14, 2017, which brought Carter Bruce L A around $412,200.

According to the SEC Form 4 filings, Carter Bruce L A has made a total of 9 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 10,000 shares on August 12, 2022, which brought Carter Bruce L A around $854,900.

According to the SEC Form 4 filings, Carter Bruce L A has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 6,000 shares on March 21, 2022, which brought Carter Bruce L A around $406,980.

More details on Carter Bruce L A's insider transactions can be found in the Insider Trading History of Carter Bruce L A table.

Insider Trading History of Carter Bruce L A

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carter Bruce L A Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carter Bruce L A Ownership Network

Ownership Network List of Carter Bruce L A

No Data

Ownership Network Relation of Carter Bruce L A


Carter Bruce L A Owned Company Details

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Carter Bruce L A is the director of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

Over the past 18 months, Carter Bruce L A made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirati Therapeutics Inc Insider Transactions

No Available Data

Carter Bruce L A Mailing Address

Above is the net worth, insider trading, and ownership report for Carter Bruce L A. You might contact Carter Bruce L A via mailing address: C/o Zymogenetics, Inc., 1201 Eastlake Avenue, Seattle Wa 98102.

Discussions on Carter Bruce L A

No discussions yet.